This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Glaxosmithkline Biologicals Sa. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Olga Slack - Innovator in Vaccine Development
Introduction
Olga Slack is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of vaccine development, particularly in the area of Lyssavirus antigen constructs. Her work focuses on creating innovative solutions to prevent and treat diseases caused by this virus.
Latest Patents
Olga holds a patent for "Lyssavirus antigen constructs." This patent describes nucleic acid-based vaccine constructs that encode Lyssaviral antigens. These constructs are designed to provide potent and long-lasting immunity against Lyssavirus-related diseases. The self-amplifying RNA molecules she developed are a key feature of her invention, enhancing the effectiveness of the vaccine.
Career Highlights
Olga Slack has established herself as a leading figure in her field. She works at GlaxoSmithKline Biologicals SA, where she continues to advance her research and development efforts. Her innovative approach to vaccine technology has garnered attention and respect within the scientific community.
Collaborations
Olga collaborates with talented professionals in her field, including Kathryn Hashey and Alan Stokes. These partnerships enhance her research capabilities and contribute to the success of her projects.
Conclusion
Olga Slack is a dedicated inventor whose work in vaccine development is making a significant impact in the fight against infectious diseases. Her innovative contributions and collaborations are paving the way for advancements in public health.